UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pattern of human monocyte subpopulations in health and disease

Scandinavian journal of immunology, 2020-07, Vol.92 (1), p.e12883-n/a

2020

Volltextzugriff (PDF)

Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases

International journal of molecular sciences, 2021-12, Vol.22 (24), p.13397

2021

Volltextzugriff (PDF)

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

The New England journal of medicine, 2020-12, Vol.383 (26), p.2526-2537

2020

Volltextzugriff (PDF)

The Role of BCL-2 and PD-1/PD-L1 Pathway in Pathogenesis of Myelodysplastic Syndromes

International journal of molecular sciences, 2023-03, Vol.24 (5), p.4708

2023

Volltextzugriff (PDF)

Polymorphisms in the Genes Coding for TLRs, NLRs and RLRs Are Associated with Clinical Parameters of Patients with Acute Myeloid Leukemia

International journal of molecular sciences, 2022-09, Vol.23 (17), p.9593

2022

Volltextzugriff (PDF)

Hematological malignancies in Polish population: what are the predictors of outcome in patients admitted to Intensive Care Unit?

Supportive care in cancer, 2021, Vol.29 (1), p.323-330

2021

Volltextzugriff (PDF)

Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study

PloS one, 2018-05, Vol.13 (5), p.e0197148-e0197148

2018

Volltextzugriff (PDF)

Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study

Translational oncology, 2021-01, Vol.14 (1), p.100943-100943, Article 100943

2021

Volltextzugriff (PDF)

Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study

Cells (Basel, Switzerland), 2021-05, Vol.10 (6), p.1293

2021

Volltextzugriff (PDF)

Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study

Journal of clinical medicine, 2021-09, Vol.10 (19), p.4373

2021

Volltextzugriff (PDF)

A survey across orbital lymphoma in Poland: Multicenter retrospective study of polish lymphoma research group (PLRG)

Cancer medicine (Malden, MA), 2023-02, Vol.12 (3), p.3036-3045

2023

Volltextzugriff (PDF)

The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study

The Lancet. Haematology, 2016-10, Vol.3 (10), p.e467-e479

2016

Volltextzugriff (PDF)

Infection and expression of Toll-like receptors in lymphoid malignancy patients after autologous stem cell transplantation

Central-European journal of immunology, 2021-01, Vol.46 (4), p.463-469

2021

Volltextzugriff (PDF)

Treatment of primary central nervous system lymphoma (PCNSL) – single center experience

Acta haematologica polonica, 2024-04

2024

Volltextzugriff (PDF)

Analysis of Polymorphism in the Genes TLR3, TLR4 and TLR9 in Patients with Acute Myeloid Leukemia

Blood, 2021-11, Vol.138 (Supplement 1), p.4470-4470

2021

Volltextzugriff (PDF)

Response to the Therapy in Hairy Cell Leukemia: Systematic Review and Meta-Analysis

Clinical lymphoma, myeloma and leukemia, 2018-06, Vol.18 (6), p.392-399.e3

2018

Volltextzugriff (PDF)

The comparison of safety and cost between reference drug of rituximab and its biosimilar Riximyo in lymphoproliferative disorders and other hematological diseases. Single center experience

Leukemia & lymphoma, 2024, Vol.65 (1), p.55-61

2024

Volltextzugriff (PDF)

A Phase 1 Dose-Escalation Study of the Cladribine Added to CPX-351 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) a Study of the Polish Adult Leukemia Group (AML-1/2018): Preliminary Results of the Dose Escalation Stage

Blood, 2022-11, Vol.140 (Supplement 1), p.6165-6166

2022

Volltextzugriff (PDF)

Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients

Journal of experimental & clinical cancer research, 2015-07, Vol.34 (1), p.68-68, Article 68

2015

Volltextzugriff (PDF)

A Phase 1 Dose-Escalation Study of the Cladribine Added to CPX-351 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) - the Polish Adult Leukemia Group AML-1/2018 Study

Blood, 2023-11, Vol.142 (Supplement 1), p.5914-5914

2023

Volltextzugriff (PDF)

Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial

The lancet oncology, 2023-02, Vol.24 (2), p.139-150

2023

Volltextzugriff (PDF)

Alterations of biomechanics in cancer and normal cells induced by doxorubicin

Biomedicine & pharmacotherapy, 2018-01, Vol.97, p.1195-1203

2018

Volltextzugriff (PDF)

Cesarean scar pregnancy complicated by uterine wall sequestration

Ginekologia polska, 2023-01, Vol.94 (5), p.425-426

2023

Volltextzugriff (PDF)

Longitudinal Assessment of Minimal Residual Disease (MRD) in the ATLAS Randomized Phase 3 Trial of Post-Transplant Treatment with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Versus Lenalidomide (R) Alone in Patients with Newly Diagnosed Multiple Myeloma (NDMM)

Blood, 2023-11, Vol.142 (Supplement 1), p.4715-4715

2023

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(77)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(48)
Humans
(34)
Oncology
(26)
Female
(25)
Hematology
(25)
Male
(24)
Middle Aged
(23)
Aged
(21)
Adult
(18)
Leukemia
(17)
Prognosis
(15)
Aged, 80 And Over
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Treatment Outcome
(13)
Acute Myeloid Leukemia
(12)
Patients
(12)
Young Adult
(11)
Chemotherapy
(10)
Retrospective Studies
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pattern of human monocyte subpopulations in health and disease

Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

The Role of BCL-2 and PD-1/PD-L1 Pathway in Pathogenesis of Myelodysplastic Syndromes

Polymorphisms in the Genes Coding for TLRs, NLRs and RLRs Are Associated with Clinical Parameters of Patients with Acute Myeloid Leukemia

Hematological malignancies in Polish population: what are the predictors of outcome in patients admitted to Intensive Care Unit?

Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study

Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study

Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study

Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study

A survey across orbital lymphoma in Poland: Multicenter retrospective study of polish lymphoma research group (PLRG)

The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study

Infection and expression of Toll-like receptors in lymphoid malignancy patients after autologous stem cell transplantation

Treatment of primary central nervous system lymphoma (PCNSL) – single center experience

Analysis of Polymorphism in the Genes TLR3, TLR4 and TLR9 in Patients with Acute Myeloid Leukemia

Response to the Therapy in Hairy Cell Leukemia: Systematic Review and Meta-Analysis

The comparison of safety and cost between reference drug of rituximab and its biosimilar Riximyo in lymphoproliferative disorders and other hematological diseases. Single center experience

A Phase 1 Dose-Escalation Study of the Cladribine Added to CPX-351 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) a Study of the Polish Adult Leukemia Group (AML-1/2018): Preliminary Results of the Dose Escalation Stage

Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients

A Phase 1 Dose-Escalation Study of the Cladribine Added to CPX-351 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) - the Polish Adult Leukemia Group AML-1/2018 Study

Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial

Alterations of biomechanics in cancer and normal cells induced by doxorubicin

Cesarean scar pregnancy complicated by uterine wall sequestration

Response to anti‐SARS‐CoV‐2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients

Longitudinal Assessment of Minimal Residual Disease (MRD) in the ATLAS Randomized Phase 3 Trial of Post-Transplant Treatment with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Versus Lenalidomide (R) Alone in Patients with Newly Diagnosed Multiple Myeloma (NDMM)

Suchergebnisse filtern